Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
7.84
0.00 (-0.06%)
Feb 11, 2026, 4:00 PM EST - Market closed
Kura Oncology Market Cap
Kura Oncology has a market cap or net worth of $681.78 million as of February 11, 2026. Its market cap has increased by 10.84% in one year.
Market Cap
681.78M
Enterprise Value
141.14M
1-Year Change
10.84%
Ranking
Category
Stock Price
$7.84
Market Cap Chart
Since November 5, 2015, Kura Oncology's market cap has increased from $113.70M to $681.78M, an increase of 499.63%. That is a compound annual growth rate of 19.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 682.20M | -24.54% |
| Dec 31, 2025 | 904.10M | 33.49% |
| Dec 31, 2024 | 677.30M | -36.58% |
| Dec 29, 2023 | 1.07B | 28.64% |
| Dec 30, 2022 | 830.20M | -10.90% |
| Dec 31, 2021 | 931.80M | -49.69% |
| Dec 31, 2020 | 1.85B | 197.24% |
| Dec 31, 2019 | 623.10M | 16.69% |
| Dec 31, 2018 | 534.00M | 15.51% |
| Dec 29, 2017 | 462.30M | 266.61% |
| Dec 30, 2016 | 126.10M | -29.75% |
| Dec 31, 2015 | 179.50M | 57.87% |
| Nov 5, 2015 | 113.70M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bright Minds Biosciences | 740.63M |
| Gyre Therapeutics | 724.40M |
| Cullinan Therapeutics | 720.14M |
| Fulcrum Therapeutics | 683.45M |
| Jade Biosciences | 667.52M |
| Replimune Group | 644.07M |
| SELLAS Life Sciences Group | 640.26M |
| enGene Holdings | 638.36M |